<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">The use of corticosteroids by COVID-19 patients has also been a confusing issue to many pharmacists. Corticosteroids were widely used during previous outbreaks of similar types of infection such as the Middle East respiratory syndrome (MERS)-CoV.
 <xref rid="bib48" ref-type="bibr">
  <sup>48</sup>
 </xref> However, although there appeared to be some evidence that corticosteroids may be beneficial if used in the early acute phase of infections, conflicting evidence from the WHO surrounding corticosteroid use in certain viral infections means this evidence is not conclusive.
 <xref rid="bib49" ref-type="bibr">
  <sup>49</sup>
 </xref> Current reports indicate no unique reason exists to expect that patients with COVID-19 infection will benefit from corticosteroids, and they might be more likely to be harmed with such treatment.
 <xref rid="bib50" ref-type="bibr">
  <sup>50</sup>
 </xref> Hence, considering the current availability of literature, caution should be exercised until further evidence emerges surrounding the use of corticosteroids in COVID-19 patients.
 <xref rid="bib51" ref-type="bibr">
  <sup>51</sup>
 </xref>
</p>
